Boner A L, Vallone G, Andreoli A, Biancotto R, Warner J O
Arch Dis Child. 1987 Mar;62(3):264-8. doi: 10.1136/adc.62.3.264.
Fifteen children with asthma underwent challenges with methacholine on separate days after double blind administration by nebuliser of either verapamil (5 mg), cromoglycate (20 mg), or saline (placebo). The provocation doses that produced a 20% fall in forced expiratory volume in one second (PD20) were analysed. There was variation in the protective effects of verapamil and cromoglycate among the patients. Although cromoglycate produced an increase in PD20 in 53% of the children tested, the protection was not significant when compared with the placebo. Verapamil was partially protective, however, in 80% of children and achieved significantly better results than the placebo. We suggest that this is likely to be due to a direct effect on bronchial smooth muscle.
15名哮喘患儿在分别通过雾化器双盲给予维拉帕米(5毫克)、色甘酸(20毫克)或生理盐水(安慰剂)后的不同日子接受了乙酰甲胆碱激发试验。分析了导致一秒用力呼气量下降20%的激发剂量(PD20)。维拉帕米和色甘酸在患者中的保护作用存在差异。虽然色甘酸在53%接受测试的儿童中使PD20增加,但与安慰剂相比,这种保护作用并不显著。然而,维拉帕米在80%的儿童中具有部分保护作用,且取得了比安慰剂显著更好的结果。我们认为这可能是由于对支气管平滑肌的直接作用。